About CALTH
-
2024
-
February
AI-Based Time-Series Algorithm Analysis Technology, Published in Nat Comm
-
April
Product Approval for COVID-19 Self-testing Kit and mobile health based EASY-ONE Pregnancy
-
-
2023
-
March
Nanotrap Technology, Published in Nat Commun.
-
April
AI Based Analysis Technology, Published in Nat Commun
-
JULY
Acquired Nanotrap technology
-
-
2022
-
January
AllCheck COVID19 Ag, MFDS listed
-
May
AllCheck COVID-19 Antigen Self-Test, obtained CE Mark
-
JULY
AllCheck COVID19 Ag and AllCheck COVID19 Ag Nasal, listed in EU Common list
-
October
Acquired SMARTAI Technology
-
October
Investment : USD 1.4M
-
-
2021
-
January
Investment : USD 7M
-
May
Factory establishment in Gunpo-si
-
June
Selected for R&D project by the Ministry of SMEs and Stratups
-
October
Launched Influneza immunodiagnostic reagent
· AllCheck Influenza A+B
-
November
KONEX listed
-
-
2020
-
January
Acquired the biosafety research facility level 2
-
May
Launched COVID-19 immunodiagnostic reagent
· AllCheck COVID-19 IgG/IgM
Investment : USD 2.3M
Acquired ISO13485 Certificate (TÜV SÜD)
-
June
Selected for 2nd step of “Collabo R&D Project” by the Ministry of SMEs and Startups
-
October
Launched COVID-19 immunodiagnostic reagent
· AllCheck COVID19 Ag
-
-
2019
-
May
Investment : USD 3M
-
June
Selected for “Collabo R&D Project” by the Ministry of SMEs and Startups
-
August
Acquired immunodiagnostics division from GenematrixBio
Investment : USD 0.5M
-
October
Acquired KGMP certificate
Listed a medical device manufacturer to MFDS
-
-
2018
-
March
Establishment of CALTH Inc.
-
April
Acquired exclusive license for ICP technology
-
May
Investment : USD 0.2M
-
July
Selected for R&D project by the Ministry of SMEs and Startups
-
September
Certified as a venture company
-
November
Certified as a Corporate R&D Center
-